195 related articles for article (PubMed ID: 7451642)
1. Hemiaplasia of the thyroid with thyrotoxicosis.
Mortimer PS; Tomlinson IW; Rosenthal FD
J Clin Endocrinol Metab; 1981 Jan; 52(1):152-5. PubMed ID: 7451642
[TBL] [Abstract][Full Text] [Related]
2. Toxic Graves' disease with thyroid hemiagenesis: diagnosis using thyroid-stimulating immunoglobulin measurements.
Shechner C; Kraiem Z; Zuckerman E; Dickstein G
Thyroid; 1992; 2(2):133-5. PubMed ID: 1356055
[TBL] [Abstract][Full Text] [Related]
3. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
Adams DD; Kennedy TH; Stewart RD
Br Med J; 1974 Apr; 2(5912):199-201. PubMed ID: 4406686
[TBL] [Abstract][Full Text] [Related]
4. Thyroid function in molar pregnancy.
Nagataki S; Mizuno M; Sakamoto S; Irie M; Shizume K
J Clin Endocrinol Metab; 1977 Feb; 44(2):254-63. PubMed ID: 402378
[TBL] [Abstract][Full Text] [Related]
5. Long-acting thyroid stimulator (LATS) and long acting thyroid stimulator protector (LATS-P) in untreated thyrotoxicosis.
Hardisty CA; Hanford L; Humphries H; Munro DS
Clin Endocrinol (Oxf); 1981 Jun; 14(6):631-9. PubMed ID: 6895353
[TBL] [Abstract][Full Text] [Related]
6. Hemiaplasia of the thyroid associated with Graves' disease: report of three cases and a review of the literature.
Ozaki O; Ito K; Mimura T; Sugino K; Kitamura Y; Iwabuchi H; Kawano M
Surg Today; 1994; 24(2):164-9. PubMed ID: 8054799
[TBL] [Abstract][Full Text] [Related]
7. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
[TBL] [Abstract][Full Text] [Related]
9. Adenomatous goiter with hyperthyroidism.
Ozaki O; Ito K; Manabe Y; Mimura T
Jpn J Surg; 1988 Mar; 18(2):146-51. PubMed ID: 3392847
[TBL] [Abstract][Full Text] [Related]
10. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
Endo K; Kasagi K; Konishi J; Ikekubo K; Okuno T; Takeda Y; Mori T; Torizuka K
J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421
[TBL] [Abstract][Full Text] [Related]
11. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and causes of undiagnosed hyperthyroidismin an adult healthy population. The Tromsø study.
Bjørndal MM; Sandmo Wilhelmsen K; Lu T; Jorde R
J Endocrinol Invest; 2008 Oct; 31(10):856-60. PubMed ID: 19092288
[TBL] [Abstract][Full Text] [Related]
13. Goiter associated with acromegaly: sonographic and scintigraphic findings of the thyroid gland.
Kasagi K; Shimatsu A; Miyamoto S; Misaki T; Sakahara H; Konishi J
Thyroid; 1999 Aug; 9(8):791-6. PubMed ID: 10482372
[TBL] [Abstract][Full Text] [Related]
14. T3-release from autonomously functioning thyroid nodules in vitro.
Poertl S; Kirner J; Saller B; Mann K; Hoermann R
Exp Clin Endocrinol Diabetes; 1998; 106(6):489-93. PubMed ID: 10079030
[TBL] [Abstract][Full Text] [Related]
15. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
[TBL] [Abstract][Full Text] [Related]
16. Low thyrotropin (TSH) levels in goiter. Relationship with scintigraphic findings and other biological parameters.
Talbot JN; Duron F; Piketty ML; Habert MO; Laforest MD; Milhaud G
Thyroidology; 1989 Apr; 1(1):39-44. PubMed ID: 2484906
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity.
Kendall-Taylor P
Br Med J; 1973 Jul; 3(5871):72-5. PubMed ID: 4740444
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of thyroidal iodothyronine 5'-monodeiodinase by long-acting thyroid stimulator (LATS).
Wu SY; Reggio R; Florsheim W; Chopra IJ; Solomon DH
Acta Endocrinol (Copenh); 1987 Feb; 114(2):193-200. PubMed ID: 3825441
[TBL] [Abstract][Full Text] [Related]
19. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia due to Graves' disease in a patient with thyroid hemiagenesis.
Kebapçilar L; Akinci B; Demir T; Bayraktar F; Yeşil S
Kulak Burun Bogaz Ihtis Derg; 2009; 19(3):159-62. PubMed ID: 19857196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
